MedPath

survey the effect of alpha-lipoic acid supplementation on some biomarkers of oxidative stress and inflammation, clinical symptoms and quality of life in patients with ulcerative colitis: a clinical trial

Phase 3
Conditions
ulcerative colitis.
K51
Registration Number
IRCT20240522061867N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
56
Inclusion Criteria

Age 25 to 55 years
Body mass index in the range of 18.5-27
Diagnosing ulcerative colitis according to clinical, colonoscopic, and histopathological findings by a gastroenterologist
Lack of cancer, other autoimmune and inflammatory diseases
Having a mild to moderate form of the disease (the severity of the disease in people is determined by a gastroenterologist based on international standards)
Not taking antioxidant supplements in the last 2 months
Willingness to participate in the intervention
Lack of pregnancy, breastfeeding, or taking oral contraceptives in women

Exclusion Criteria

Recurrence of the disease that leads to hospitalization
Unwillingness to continue participating in the intervention
Changing the drug dose during the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath